Ebola virus does not block apoptotic signaling pathways.

Judith Olejnik, Jesus Alonso, Kristina M Schmidt, Zhen Yan, Wei Wang, Andrea Marzi, Hideki Ebihara, Jinghua Yang, Jean L Patterson, Elena Ryabchikova, Elke Mühlberger
Author Information
  1. Judith Olejnik: Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, USA.

Abstract

Since viruses rely on functional cellular machinery for efficient propagation, apoptosis is an important mechanism to fight viral infections. In this study, we sought to determine the mechanism of cell death caused by Ebola virus (EBOV) infection by assaying for multiple stages of apoptosis and hallmarks of necrosis. Our data indicate that EBOV does not induce apoptosis in infected cells but rather leads to a nonapoptotic form of cell death. Ultrastructural analysis confirmed necrotic cell death of EBOV-infected cells. To investigate if EBOV blocks the induction of apoptosis, infected cells were treated with different apoptosis-inducing agents. Surprisingly, EBOV-infected cells remained sensitive to apoptosis induced by external stimuli. Neither receptor- nor mitochondrion-mediated apoptosis signaling was inhibited in EBOV infection. Although double-stranded RNA (dsRNA)-induced activation of protein kinase R (PKR) was blocked in EBOV-infected cells, induction of apoptosis mediated by dsRNA was not suppressed. When EBOV-infected cells were treated with dsRNA-dependent caspase recruiter (dsCARE), an antiviral protein that selectively induces apoptosis in cells containing dsRNA, virus titers were strongly reduced. These data show that the inability of EBOV to block apoptotic pathways may open up new strategies toward the development of antiviral therapeutics.

References

  1. Viral Immunol. 2004;17(3):390-400 [PMID: 15357905]
  2. J Virol. 2005 Jul;79(14):9320-4 [PMID: 15994827]
  3. J Biol Chem. 2004 Apr 9;279(15):15652-61 [PMID: 14739303]
  4. Cell Signal. 2004 Feb;16(2):139-44 [PMID: 14636884]
  5. J Virol. 2008 Oct;82(20):10102-10 [PMID: 18684815]
  6. Cell Death Differ. 2007 Jul;14(7):1237-43 [PMID: 17431418]
  7. Biochem Pharmacol. 2008 Feb 1;75(3):589-602 [PMID: 17868652]
  8. Microbes Infect. 2009 Nov;11(13):1050-62 [PMID: 19733681]
  9. J Infect Dis. 1999 Feb;179 Suppl 1:S199-202 [PMID: 9988185]
  10. Viruses. 2011 Aug;3(8):1501-31 [PMID: 21927676]
  11. Oncogene. 2003 Nov 24;22(53):8543-67 [PMID: 14634618]
  12. Curr Opin Virol. 2012 Apr;2(2):151-6 [PMID: 22482712]
  13. Cell Host Microbe. 2010 Apr 22;7(4):302-313 [PMID: 20413098]
  14. PLoS One. 2011;6(7):e22572 [PMID: 21818340]
  15. Virus Res. 2002 Jun;86(1-2):87-92 [PMID: 12076832]
  16. Mol Cell. 2012 Dec 28;48(6):888-99 [PMID: 23142077]
  17. EMBO J. 2010 May 19;29(10):1762-73 [PMID: 20360684]
  18. Comp Biochem Physiol B Biochem Mol Biol. 2008 Sep;151(1):10-27 [PMID: 18602321]
  19. J Virol. 1999 Jan;73(1):702-8 [PMID: 9847376]
  20. J Pathol. 1978 Jul;125(3):131-8 [PMID: 102747]
  21. J Interferon Cytokine Res. 2011 Jan;31(1):59-70 [PMID: 21166592]
  22. J Infect Dis. 2011 Nov;204 Suppl 3:S861-70 [PMID: 21987762]
  23. J Virol. 2009 Sep;83(17):8993-7 [PMID: 19515768]
  24. Apoptosis. 2005 Jan;10(1):153-66 [PMID: 15711931]
  25. Autophagy. 2009 Jul;5(5):590-603 [PMID: 19363298]
  26. Virology. 2005 Feb 5;332(1):20-7 [PMID: 15661137]
  27. Immunology. 2009 Jun;127(2):145-54 [PMID: 19476510]
  28. J Gen Virol. 1979 Apr;43(1):247-52 [PMID: 113494]
  29. Viruses. 2011 Sep;3(9):1634-49 [PMID: 21994800]
  30. FEBS Lett. 2002 Oct 9;529(2-3):249-55 [PMID: 12372609]
  31. Clin Exp Immunol. 2001 Jun;124(3):453-60 [PMID: 11472407]
  32. J Infect Dis. 2007 Nov 15;196 Suppl 2:S313-22 [PMID: 17940966]
  33. Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):314-9 [PMID: 20018665]
  34. Nat Struct Mol Biol. 2010 Feb;17(2):165-72 [PMID: 20081868]
  35. Virology. 2010 Jun 20;402(1):203-8 [PMID: 20394957]
  36. J Virol. 2000 Apr;74(8):3781-92 [PMID: 10729153]
  37. Cell Death Differ. 2001 Jun;8(6):588-94 [PMID: 11536009]
  38. Cell Death Differ. 2012 Jan;19(1):75-86 [PMID: 22075985]
  39. Apoptosis. 2005 Jan;10(1):167-76 [PMID: 15711932]
  40. Biosecur Bioterror. 2011 Dec;9(4):361-71 [PMID: 22070137]
  41. Cell Commun Signal. 2010 Dec 22;8:31 [PMID: 21176168]
  42. Cell Death Differ. 2012 Sep;19(9):1482-94 [PMID: 22421964]
  43. Curr Med Chem Anticancer Agents. 2003 Jul;3(4):271-90 [PMID: 12769773]
  44. Virology. 2007 Jul 20;364(1):45-54 [PMID: 17391724]
  45. Clin Exp Immunol. 2002 Apr;128(1):163-8 [PMID: 11982604]
  46. Oncogene. 2003 Nov 24;22(53):8628-33 [PMID: 14634624]
  47. Virology. 2006 Jul 20;351(1):101-11 [PMID: 16631220]
  48. J Virol. 2010 Jan;84(1):27-33 [PMID: 19846529]
  49. J Virol. 2003 Sep;77(17):9156-72 [PMID: 12915532]
  50. J Cell Mol Med. 2003 Jul-Sep;7(3):249-57 [PMID: 14594549]
  51. Nat Med. 1999 Apr;5(4):423-6 [PMID: 10202932]
  52. Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):337-48 [PMID: 12787570]
  53. FASEB J. 2011 May;25(5):1767-74 [PMID: 19880628]
  54. N Engl J Med. 2009 Oct 15;361(16):1570-83 [PMID: 19828534]
  55. J Immunol. 2001 Sep 15;167(6):3164-73 [PMID: 11544302]
  56. Lab Invest. 2000 Feb;80(2):171-86 [PMID: 10701687]
  57. PLoS Negl Trop Dis. 2010 Oct 05;4(10): [PMID: 20957152]
  58. Immunol Cell Biol. 2011 Oct;89(7):792-802 [PMID: 21263462]
  59. J Immunol. 2010 Jan 1;184(1):327-35 [PMID: 20028660]
  60. Immunol Lett. 2002 Mar 1;80(3):169-79 [PMID: 11803049]
  61. Biochimie. 2007 Jun-Jul;89(6-7):799-811 [PMID: 17451862]
  62. Cell. 2009 Jun 12;137(6):1112-23 [PMID: 19524513]
  63. J Gen Virol. 2010 Feb;91(Pt 2):352-61 [PMID: 19828757]
  64. J Virol. 2007 Jan;81(1):182-92 [PMID: 17065211]
  65. Am J Pathol. 2003 Dec;163(6):2347-70 [PMID: 14633608]
  66. Nat Rev Cancer. 2005 Nov;5(11):886-97 [PMID: 16239905]
  67. PLoS One. 2011 Apr 05;6(4):e18291 [PMID: 21483669]
  68. Blood. 2002 Dec 15;100(13):4446-53 [PMID: 12393560]
  69. Genome Biol. 2007;8(8):R174 [PMID: 17725815]
  70. Annu Rev Microbiol. 2008;62:171-92 [PMID: 18729734]
  71. J Infect Dis. 2007 Nov 15;196 Suppl 2:S296-304 [PMID: 17940964]
  72. J Infect Dis. 2003 Dec 1;188(11):1630-8 [PMID: 14639532]
  73. Apoptosis. 2000 Apr;5(2):107-14 [PMID: 11232238]
  74. J Virol. 2006 May;80(10):5059-64 [PMID: 16641297]
  75. PLoS Pathog. 2009 Jun;5(6):e1000493 [PMID: 19557165]
  76. Arch Virol. 1996;141(5):909-21 [PMID: 8678836]
  77. Apoptosis. 2000 Feb;5(1):5-7 [PMID: 11227491]
  78. Cell Death Differ. 2004 Apr;11(4):439-47 [PMID: 14713960]

Grants

  1. C06 RR012087/NCRR NIH HHS
  2. U01 AI082954/NIAID NIH HHS
  3. U01-AI082954/NIAID NIH HHS
  4. CO6 RR12087/NCI NIH HHS

MeSH Term

Animals
Cell Death
Chlorocebus aethiops
Ebolavirus
HeLa Cells
Humans
Signal Transduction
Vero Cells

Word Cloud

Created with Highcharts 10.0.0apoptosiscellsEBOVEBOV-infectedcelldeathvirusdsRNAmechanismEbolainfectiondatainfectedinductiontreatedsignalingproteinantiviralblockapoptoticpathwaysSincevirusesrelyfunctionalcellularmachineryefficientpropagationimportantfightviralinfectionsstudysoughtdeterminecausedassayingmultiplestageshallmarksnecrosisindicateinduceratherleadsnonapoptoticformUltrastructuralanalysisconfirmednecroticinvestigateblocksdifferentapoptosis-inducingagentsSurprisinglyremainedsensitiveinducedexternalstimuliNeitherreceptor-mitochondrion-mediatedinhibitedAlthoughdouble-strandedRNA-inducedactivationkinaseRPKRblockedmediatedsuppresseddsRNA-dependentcaspaserecruiterdsCAREselectivelyinducescontainingtitersstronglyreducedshowinabilitymayopennewstrategiestowarddevelopmenttherapeutics

Similar Articles

Cited By